Precision BioSciences Q3 net loss narrows 65% to $7.59 million
Bitget2026/11/03 12:10- Precision BioSciences' third-quarter 2026 net loss narrowed 65% year-over-year to $7.59 million, primarily due to noncash warrant liability fair-value gains.
- Revenue fell to none, while operating expenses declined to $20.43 million from a year earlier.
- Cash, cash equivalents and restricted cash totaled $108.03 million at September 30, with expected funding runway through 2028.
- PBGENE-HBV clinical data will feature in a late-breaking oral presentation at AASLD's Liver Meeting on November 8.
- The first patient received PBGENE-DMD in August, with initial safety data targeted for year-end 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As Bitcoin Fell, a Billion-Dollar Gap Emerged at Michael Saylor’s Company—What Are the Costs Per BTC?

Tesla opens Cybercab purchases to invited individuals, starting at $29,990, with the first deliveries in December.
Tesla has officially opened reservations for the steering wheel-free Cybercab to individual consumers, with a starting price of $29,990 and the first deliveries scheduled for December 2026. This driverless two-seater electric vehicle will become Tesla’s lowest-priced model, and Elon Musk is even willing to halt production of the Cybertruck to prioritize it. However, the NHTSA has launched an investigation, and regulatory uncertainties may cast doubt on the commercialization of autonomous driving.

A certain exchange suspends KAVA deposit and withdrawal services

Don't be scared by the Nvidia turmoil and election noise! Morgan Stanley: AI turbulence does not change the main driver of the bull market, long-term outlook remains "extremely bullish"
The Chief Investment Officer of Morgan Stanley Wealth Management stated that management turmoil at Nvidia and the Democratic Party's victory in the midterm elections have further heightened market concerns about the AI sector. However, these factors will not shake the core driving force of this bull market—capital expenditure on AI infrastructure.
